Alea Sciences is at the forefront of transforming how skin-related information is collected, opening new avenues for developing next-generation drugs for skin diseases. We specialize in creating medical-grade adhesive tapes for non-invasive skin tissue collection, integrated with cutting-edge laboratory processes and advanced data analysis techniques to support biopharma drug developers in dermatology clinical trials. Our innovative adhesive tapes provide a patient-friendly alternative to invasive skin biopsies, significantly reducing patient burden during dermatology clinical trials. Our laboratory and analytical processes deliver a robust translational platform for dermatology drug development by generating comprehensive multi-omics skin biomarker discovery datasets using next-generation sequencing (NGS) technologies, including RNA-sequencing, high-throughput proteomics and skin microbiome profiling. Our expert bioinformatics team delivers insightful data analyses, helping biopharma companies derive actionable insights to support their dermatology drug development efforts. The services address a broad range of skin indications, including skin cancer, inflammatory, and autoimmune disorders. In addition to our focus on non-invasive skin sampling, Alea Sciences can also facilitate the processing of other sample types collected during dermatology trials (e.g. blood). This integrated strategy allows us to offer comprehensive data that enhance the understanding of skin diseases. We look forward to partnering with you in supporting your dermatological research and clinical trial needs.